EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19

Christina M Kackos iD, Sherri L Surman, Bart G Jones, Robert E Sealy, Trushar Jeevan, Christopher J H Davitt, Sergei Pustylnikov, Tamarand L Darling, Adrianus C M Boon iD, Julia L Hurwitz, Marcelo M Samsa, Richard J Webby iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.04240-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Christina M Kackos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, mRNA Vaccines, SARS-CoV-2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, GreenLight Bioscience, American Lebanese Syrian Associated Charities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 continues to disrupt everyday life and cause excess morbidity and mortality worldwide. Vaccination has been key to quelling the impact of this respiratory pathogen, and mRNA vaccines have led the charge on this front.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesmRNA VaccinesSARS-CoV-2AnimalsCricetinaeHumansMiceAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

SARS-CoV-2coronavirusmRNAvaccinesvirology

Substanzen

Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesmRNA Vaccinesspike protein, SARS-CoV-2Spike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • St. Jude Children's Research Hospital Graduate School of Biomedical Sciences, Memphis, Tennessee, USA.
  • GreenLight Biosciences, Woburn, Massachusetts, USA.
  • Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.

ORCID-Profile: Christina M Kackos, Adrianus C M Boon, Richard J Webby

Förderung

  • NIAID NIH HHS
  • GreenLight Bioscience
  • American Lebanese Syrian Associated Charities
  • HHS | NIH | National Cancer Institute
  • HHS | National Institutes of Health

Zitieren

APA

Kackos, C. M., Surman, S. L., Jones, B. G., Sealy, R. E., Jeevan, T., Davitt, C. J. H., Pustylnikov, S., Darling, T. L., Boon, A. C. M., Hurwitz, J. L., Samsa, M. M., & Webby, R. J. (2023). mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04240-22

Vancouver

Kackos CM, Surman SL, Jones BG, Sealy RE, Jeevan T, Davitt CJH, et al. mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19. Microbiology Spectrum. 2023. doi:10.1128/spectrum.04240-22

BibTeX
@article{Kackos2023,
  author = {Kackos, Christina M and Surman, Sherri L and Jones, Bart G and Sealy, Robert E and Jeevan, Trushar and Davitt, Christopher J H and Pustylnikov, Sergei and Darling, Tamarand L and Boon, Adrianus C M and Hurwitz, Julia L and Samsa, Marcelo M and Webby, Richard J},
  title = {mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.04240-22}
}
Kostenlos starten →